Evidence map›Paper›PMID 42908394›Full record

ArticleEchocardiography (Mount Kisco, N.Y.)2026

Early Prediction of Cardiomyopathy in Pediatric Cancer Survivors Using Echocardiographic Video-Based Deep Learning.

Surbhi Sharma, Brandy Martinez Di Pietro, Ananya Nandula, Tanishka Goplani, Hanpeng Chen, Saro Armenian, Aarti Bhat, Nancy Blythe, William Border, Kasey J Leger and 10 more

Abstract read
In one paragraph

Article in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Surbhi SharmaDepartment of Bioengineering, University of Washington, Seattle, Washington, USA.
Brandy Martinez Di PietroSeattle Children's Hospital, Seattle, Washington, USA.
Ananya NandulaDepartment of Bioengineering, University of Washington, Seattle, Washington, USA.
Tanishka GoplaniDepartment of Bioengineering, University of Washington, Seattle, Washington, USA.
Hanpeng ChenDepartment of Bioengineering, University of Washington, Seattle, Washington, USA.
Saro ArmenianDepartments of Pediatrics and Population Sciences, City of Hope, Duarte, California, USA.
Aarti BhatSeattle Children's Hospital, Seattle, Washington, USA.
Nancy BlytheClinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
William BorderDepartment Of Pediatrics, Emory University, Atlanta, Georgia, USA.
Kasey J LegerSeattle Children's Hospital, Seattle, Washington, USA.
Wendy M LeisenringClinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Lillian R MeachamDepartment Of Pediatrics, Emory University, Atlanta, Georgia, USA.
Shanti NarasimhanDepartment Of Pediatrics, University of Minnesota, Masonic Children's Hospital, Minneapolis, Minnesota, USA.
Paul C NathanDepartment Of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ritu SachdevaDepartment Of Pediatrics, Emory University, Atlanta, Georgia, USA.
Karim SadakDepartment Of Pediatrics, University of Minnesota, Masonic Children's Hospital, Minneapolis, Minnesota, USA.
Kayla StrattonClinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Eric J ChowSeattle Children's Hospital, Seattle, Washington, USA.
Lindsay A Edwards *Department Of Pediatrics, University of Washington, Seattle, Washington, USA.
Patrick M Boyle *Department of Bioengineering, University of Washington, Seattle, Washington, USA.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
Towards a preventive cancer vaccine for children with constitutional mismatch repair deficiencyUG1CA189955 · NCI · PUBLIC HEALTH INSTITUTE · PI BRAD H POLLOCK, Michael E. Roth · 2014 to 2026
$62.5M
Dexrazoxane and Prevention of Anthracycline-Related CardiomyopathyR01CA211996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHOW, ERIC JESSEN, LIPSHULTZ, STEVEN EDWARD · 2017 to 2020
$2.7M
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer SurvivorsR21CA277746 · NCI · FRED HUTCHINSON CANCER CENTER · PI BOYLE, PATRICK M, CHOW, ERIC JESSEN · 2023 to 2024
$441k
Machine learning-enhanced cardiomyopathy prediction in childhood cancer survivorsK23HL183696 · NHLBI · DUKE UNIVERSITY · PI Lindsay Atherton Edwards · 2026 to 2026
$177k
Catherine Holmes Wilkins Charitable FoundationNIH HHS K23HL183696NIH HHS R01CA211996NIH HHS R21CA277746NIH HHS U10CA180886NIH HHS UG1CA189955Rally FoundationSeattle Children's Research InstituteSeattle Foundation Medical Funds ProgramUnravel Pediatric Cancer Foundation
6 · The paper itself

Abstract

purposeCardiomyopathy (CM) is a leading cause of late mortality in childhood cancer survivors, but it is often identified only after irreversible cardiac remodeling has already occurred. In this proof-of-concept study, we assessed whether deep learning applied to routine echocardiographic videos can identify features predictive of future CM.

methodsWe analyzed parasternal short-axis clips from cancer survivors ≤21 years old at cancer diagnosis. 3D deep convolutional neural networks were trained to classify CM-positive versus CM-negative studies from echocardiograms conducted up to five years prior to CM diagnosis. The performance was assessed on internal hold-out validation (Center 1) and external validation cohorts (Centers 2, 3). The model's prognostic value was evaluated by stratifying patients into high- and low-risk groups for developing CM, and probability of future CM was assessed using cumulative incidence and proportional hazards regression analysis.

resultsThe model achieved an area under the receiver operating characteristic curve (AUROC) of 0.87±0.05 and an area under the precision-recall curve (AUPRC) of 0.74±0.07 on the internal hold-out set. External validation showed near-chance single-study discrimination (AUROC 0.55±0.02 and 0.60±0.03; AUPRC 0.22±0.02 and 0.21±0.03 for Centers 2 and 3, respectively). Nevertheless, analysis of the external cohort showed significantly higher probability of CM in high- versus low-risk groups (hazard ratio 2.78, 95% CI = 1.52-5.10, p = 0.00056).

conclusionDeep learning models have the potential to identify subtle echocardiographic markers years before CM diagnosis in pediatric cancer survivors and could serve as a preliminary step toward risk-guided CM surveillance. Further refinement and validation are needed to determine the utility of deep learning for early identification of pathologic cardiac remodeling in this population.

Indexed as

Cancer SurvivorsCardiomyopathiesDeep LearningEchocardiographyNeoplasmsVideo RecordingAdolescentChildChild, PreschoolFemaleHumansInfantMalePredictive Value of TestsPrognosisYoung Adultcancer survivorscardiomyopathiescardiotoxicityechocardiographymachine learning

Identifiers

PMID42908394
PMCPMC13687910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.